Related Experiment Video
Updated: Nov 12, 2025

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
Published on: August 24, 2021
Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis
1Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA; Department of Hepatobiliary Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210000, China.
Abstract:
Many cancers, including pancreatic ductal adenocarcinoma (PDAC), depend on autophagy-mediated scavenging and recycling of intracellular macromolecules, suggesting that autophagy blockade should cause tumor starvation and regression. However, until now autophagy-inhibiting monotherapies have not demonstrated potent anti-cancer activity. We now show that autophagy blockade prompts established PDAC to upregulate and utilize an alternative nutrient procurement pathway: macropinocytosis (MP) that allows tumor cells to extract nutrients from extracellular sources and use them for energy generation. The autophagy to MP switch, which may be evolutionarily conserved and not cancer cell restricted, depends on activation of transcription factor NRF2 by the autophagy adaptor p62/SQSTM1. NRF2 activation by oncogenic mutations, hypoxia, and oxidative stress also results in MP upregulation. Inhibition of MP in autophagy-compromised PDAC elicits dramatic metabolic decline and regression of transplanted and autochthonous tumors, suggesting the therapeutic promise of combining autophagy and MP inhibitors in the clinic.
Insights
Pancreatic cancer cells adapt to autophagy inhibition by increasing macropinocytosis for nutrients. Combining autophagy and macropinocytosis inhibitors may offer a potent anti-cancer therapy for pancreatic ductal adenocarcinoma.
Area of Science:
- Oncology
- Cellular Biology
- Cancer Metabolism
Background:
- Pancreatic ductal adenocarcinoma (PDAC) relies on autophagy for nutrient recycling.
- Autophagy-inhibiting drugs have shown limited efficacy as monotherapies for cancer.
- Understanding alternative nutrient pathways is crucial for effective cancer treatment.
Purpose of the Study:
- To investigate the adaptive mechanisms of PDAC cells upon autophagy blockade.
- To identify alternative nutrient acquisition pathways utilized by cancer cells.
- To explore the therapeutic potential of targeting these adaptive pathways.
Main Methods:
- Utilized established PDAC cell models and in vivo tumor models.
- Investigated the role of autophagy, macropinocytosis, and the NRF2 pathway.
- Assessed the impact of inhibiting macropinocytosis in autophagy-compromised tumors.
Main Results:
- Autophagy blockade in PDAC triggers upregulation of macropinocytosis (MP) for nutrient uptake.
- The switch to MP is regulated by the p62/SQSTM1-NRF2 signaling axis.
- Inhibition of MP in autophagy-impaired PDAC tumors led to significant metabolic decline and tumor regression.
Conclusions:
- PDAC cells adapt to autophagy inhibition by activating macropinocytosis.
- The p62/SQSTM1-NRF2 pathway mediates this adaptive switch.
- Combined inhibition of autophagy and macropinocytosis presents a promising therapeutic strategy for PDAC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...

